Search Form
First, enter a politician or zip code
Now, choose a category

Public Statements

GAIN Act Advances in the House


Location: Unknown

As a result of legislation I authored, the GAIN Act, the FDA this week conferred special status to delafloxacin, a new drug being developed for use in hospitals as a "first-line" antibiotic. The bipartisan GAIN Act, signed into law in July, aims to spur development of new drugs to treat the growing number of "superbugs." It also streamlines and fast-tracks the FDA review process, ensuring patients have access to life-saving treatments. The drug is under development to treat lung infections, including pneumonia and bronchitis, and skin infections.

Skip to top
Back to top